The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States: (548692006-002)
Abstract
On May 2, 2005, a new in vitro test, QuantiFERON-TB Gold (QFT-G, Cellestis Limited, Carnegie, Victoria, Australia), received final approval from the U.S. Food and Drug Administration as an aid for diagnosing Mycobacterium tuberculosis infection. This test detects the release of interferon-gamma (IFN-g) in fresh heparinized whole blood from sensitized persons when it is incubated with mixtures of synthetic peptides representing two proteins present in M. tuberculosis: early secretory antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10). These antigens impart greater specificity than is possible with tests using purified protein derivative as the tuberculosis (TB) antigen. In direct comparisons, the sensitivity of QFT-G was statistically similar to that of the tuberculin skin test (TST) for detecting infection in persons with untreated culture-confirmed tuberculosis (TB). The performance of QFT-G in certain populations targeted by TB control programs in the United States for finding latent TB infection is under study. Its ability to predict who eventually will have TB disease has not been determined, and years of observational study of substantial populations would be needed to acquire this information. In July 2005, CDC convened a meeting of consultants and researchers with expertise in the field to review scientific evidence and clinical experience with QFT-G. On the basis of this review and discussion, CDC recommends that QFT-G may be used in all circumstances in which the TST is currently used, including contact investigations, evaluation of recent immigrants, and sequential-testing surveillance programs for infection control (e.g., those for health-care workers). This report provides specific cautions for interpreting negative QFT-G results in persons from selected populations. This report is aimed at public health officials, health-care providers, and laboratory workers with responsibility for TB control activities in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Specific immune-based diagnosis of tuberculosis
Andersen, P., Munk, M., Pollock, J., & Doherty, T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02742-2 · Cited by 924
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
Pai, M., Riley, L. W., & Colford, J. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01206-x · Cited by 913
Specific Detection of Tuberculosis Infection: An Interferon-γ–based Assay Using New Antigens
Mori, T., Sakatani, M., Yamagishi, F., Takashima, T., Kawabe, Y., Nagao, K., Shigeto, E., Harada, N., Mitarai, S., Okada, M., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-179oc · Cited by 657
Ewer, K., Deeks, J., Alvarez, L., Bryant, G., Waller, S., Andersen, P., Monk, P., & Lalvani, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12950-9 · Cited by 615
Interpretation of Repeated Tuberculin Tests: Boosting, Conversion, and Reversion
MENZIES, D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9801120 · Cited by 488
Comparison of Tuberculin Skin Test and New Specific Blood Test in Tuberculosis Contacts
Brock, I., Weldingh, K., Lillebaek, T., Follmann, F., & Andersen, P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-232oc · Cited by 333
Hirsch, C. S., Toossi, Z., Othieno, C., Johnson, J. L., Schwander, S. K., Robertson, S., Wallis, R. S., Edmonds, K., Okwera, A., Mugerwa, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315114 · Cited by 275
Cited by
Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
Pai, M., Zwerling, A., & Menzies, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00241 · Cited by 1,339
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Menzies, D., Pai, M., & Comstock, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00006 · Cited by 984
Pathirana, D., Ormerod, A., Saiag, P., Smith, C., Spuls, P., Nast, A., Barker, J., Bos, J., Burmester, G., Chimenti, S., et al. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03389.x · Cited by 703
Intraocular Tuberculosis—An Update
Gupta, V., Gupta, A., & Rao, N. A. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.08.015 · Cited by 680
Kinetoplastids: related protozoan pathogens, different diseases
Stuart, K., Brun, R., Croft, S., Fairlamb, A., Gürtler, R. E., McKerrow, J., Reed, S., & Tarleton, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33945 · Cited by 604
Mack, U., Migliori, G. B., Sester, M., Rieder, H. L., Ehlers, S., Goletti, D., Bossink, A., Magdorf, K., Hölscher, C., Kampmann, B., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00120908 · Cited by 591
Diel, R., Goletti, D., Ferrara, G., Bothamley, G., Cirillo, D., Kampmann, B., Lange, C., Losi, M., Markova, R., Migliori, G. B., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00115110 · Cited by 544
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
Parsons, L. M., Somoskövi, Á., Gutierrez, C., Lee, E., Paramasivan, C. N., Abimiku, A., Spector, S., Roscigno, G., & Nkengasong, J. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-10 · Cited by 540
Ferrara, G., Losi, M., D'Amico, R., Roversi, P., Piro, R., Meacci, M., Meccugni, B., Dori, I. M., Andreani, A., Bergamini, B. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68579-6 · Cited by 505
Ahmed, Q. A., Arabi, Y. M., & Memish, Z. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68429-8 · Cited by 411
Diagnosing Tuberculosis Infection in the 21st Century
Lalvani, A. (2007) · Chest · doi:10.1378/chest.06-2471 · Cited by 350
An Update on the Diagnosis of Tuberculosis Infection
Richeldi, L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1516pp · Cited by 346
Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria
Forbes, B. A., Hall, G. S., Miller, M. B., Novak, S. M., Rowlinson, M.-C., Salfinger, M., Somoskövi, A., Warshauer, D. M., & Wilson, M. L. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00038-17 · Cited by 311
Detjen, A. K., Keil, T., Roll, S., Hauer, B., Mauch, H., Wahn, U., & Magdorf, K. (2007) · Clinical Infectious Diseases · doi:10.1086/519266 · Cited by 288
Winthrop, K. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0336 · Cited by 280
Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ Assay
Pai, M., Joshi, R., Dogra, S., Mendiratta, D. K., Narang, P., Kalantri, S., Reingold, A. L., Colford, J. M., Riley, L. W., & Menzies, D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-472oc · Cited by 275
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Lee, J. Y., Choi, H. J., Park, I.-N., Hong, S.-B., Oh, Y.-M., Lim, C.-M., Lee, S. D., Koh, Y., Kim, W. S., Kim, D. S., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00016906 · Cited by 257
Comparison of Two Interferon-γ Assays and Tuberculin Skin Test for Tracing Tuberculosis Contacts
Arend, S. M., Thijsen, S. F. T., Leyten, E. M. S., Bouwman, J. J. M., Franken, W. P. J., Koster, B. F. P. J., Cobelens, F. G. J., van Houte, A.-J., & Bossink, A. W. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1099oc · Cited by 255
Differentiating Intestinal Tuberculosis From Crohn's Disease: A Diagnostic Challenge
Almadi, M. A., Ghosh, S., & Aljebreen, A. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.162 · Cited by 254
Andrade, B. B., Pavan Kumar, N., Mayer-Barber, K. D., Barber, D. L., Sridhar, R., Rekha, V. V. B., Jawahar, M. S., Nutman, T. B., Sher, A., & Babu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062618 · Cited by 64
Song, K.-H., Jeon, J. H., Park, W. B., Kim, S.-H., Park, K. U., Kim, N. J., Oh, M.-D., Kim, H. B., & Choe, K. W. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.10.013 · Cited by 68
Tabuchi, T., Takatorige, T., Hirayama, Y., Nakata, N., Harihara, S., Shimouchi, A., Fujita, K., Yoshida, H., Tamura, Y., Nagai, T., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-22 · Cited by 38
“QFT results were considered indeterminate if the subject did not respond to the mitogen-positive control tube with at least 0.5 IU/ml of interferon-g [19, 20 ].”
MethodInfluential
Metadata
- Venue
- PsycEXTRA Dataset
- Published
- 2005
- Volume
- 54
- Issue
- RR-15
- Pages
- 49-55
- OpenAlex
- W2113724100
- Cited by
- 691
- References
- 14
- Type
- dataset
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.